RT Journal Article
SR Electronic
T1 Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1000
OP 1004
DO 10.3899/jrheum.131310
VO 41
IS 5
A1 Tugwell, Peter
A1 Boers, Maarten
A1 D’Agostino, Maria-Antonietta
A1 Beaton, Dorcas
A1 Boonen, Annelies
A1 Bingham, Clifton O.
A1 Choy, Ernest
A1 Conaghan, Philip G.
A1 Dougados, Maxime
A1 Duarte, Catia
A1 Furst, Daniel E.
A1 Guillemin, Francis
A1 Gossec, Laure
A1 Heiberg, Turid
A1 van der Heijde, Désirée M.
A1 Hewlett, Sarah
A1 Kirwan, John R.
A1 Kvien, Tore K.
A1 Landewé, Robert B.
A1 Mease, Philip J.
A1 Østergaard, Mikkel
A1 Simon, Lee
A1 Singh, Jasvinder A.
A1 Strand, Vibeke
A1 Wells, George
YR 2014
UL http://www.jrheum.org/content/41/5/1000.abstract
AB Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The “Truth” section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity. Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved. Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address. Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.